p-120 catenin is a useful diagnostic biomarker for distinguishing plasmacytoid and sarcomatoid variants from conventional urothelial carcinoma

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Context.-Plasmacytoid urothelial carcinoma (PC-UC) is an aggressive variant of urothelial carcinoma (UC), characterized by loss of E-cadherin (E-Cad)-mediated intercellular adhesion. Loss of E-Cad by immunohistochemistry can help diagnose PC-UC; however, sensitivity is limited. Expression of other cadherin-catenin adhesion complex members, that is, p-120 catenin (p-120) and b-catenin (B-Cat), which are diagnostically useful for lobular breast carcinoma, remains unknown in UC. Objective.-To determine the utility of p-120 and B-Cat in conventional and variant UC. Design.-E-cadherin, B-Cat, and p-120 immunohistochemistry was performed in 25 conventional UCs and 33 variant UCs, including 22 PC-UCs, 6 sarcomatoid UCs (SUCs), and 5 micropapillary UCs. Membranous staining for all biomarkers was considered normal; however, any cytoplasmic staining or an absence of staining was considered diagnostically abnormal. Next-generation sequencing was performed on 8 PC-UC cases. Results.-E-cadherin, B-Cat, and p-120 showed membranous staining in all conventional and micropapillary UCs. In contrast, most PC-UCs were negative for E-Cad (17 of 22; 77%) with an additional 2 of 22 cases (9%) showing cytoplasmic with partial membranous staining. p-120 catenin demonstrated cytoplasmic or negative staining in 21 of 22 cases (95%). Most SUCs showed an absence of E-Cad (5 of 6; 83%) and cytoplasmic or negative p-120 in 5 of 6 cases (83%). Staining for B-Cat was also abnormal in a subset of PC-UCs and SUCs. Five PC-UC cases that harbored CDH1 gene variants were p-120 cytoplasmic positive. Conclusions.-p-120 catenin is a useful adjunct biomarker to E-Cad in the clinically important distinction of PC-UC and SUC from conventional UC. In particular, the combination of cytoplasmic p-120 and loss of E-Cad is strongly supportive of PC-UC and SUC.

References Powered by Scopus

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

1639Citations
N/AReaders
Get full text

Validation of oncopanel a targeted next-generation sequencing assay for the detection of somatic variants in cancer

373Citations
N/AReaders
Get full text

Institutional implementation of clinical tumor profiling on an unselected cancer population

348Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications

1Citations
N/AReaders
Get full text

Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings

1Citations
N/AReaders
Get full text

Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Acosta, A. M., Barletta, J., Sonpavde, G., Schnitt, S., & Hirsch, M. S. (2021). p-120 catenin is a useful diagnostic biomarker for distinguishing plasmacytoid and sarcomatoid variants from conventional urothelial carcinoma. Archives of Pathology and Laboratory Medicine, 145(8), 1000–1008. https://doi.org/10.5858/arpa.2020-0262-oa

Readers over time

‘20‘21‘2300.511.52

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 1

25%

Medicine and Dentistry 1

25%

Veterinary Science and Veterinary Medic... 1

25%

Social Sciences 1

25%

Save time finding and organizing research with Mendeley

Sign up for free
0